C Saloma|S Kawata|S Minami - JoVE Visualize

Showing results (461-470 of 666) with videos related to

Pageof 67

Sort By:

Journal of Hepatology|January 1, 1990

Inhibitory effect of a new alpha-glucosidase inhibitor on fatty liver in Zucker fatty ratsY Inui, S Kawata, Y Matsuzawa, et al.

Journal of Hepatology|February 2, 1999

Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosisH Tsushima, S Kawata, S Tamura, et al.

Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1987

[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT]M Inada, Y Minami, S Kawata, et al.

Infection and Immunity|August 1, 1979

Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigsH Takada, M Tsujimoto, S Kotani, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995

Increased mitogenic response to heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells of diabetic ratsK Fukuda, Y Inui, S Kawata, et al.

Journal of Lipid Research|August 1, 1995

Increased proportion of plasma apoB-48 to apoB-100 in non-insulin-dependent diabetic rats: contribution of enhanced apoB mRNA editing in the liverM Yamane, S Jiao, S Kihara, et al.

Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1984

[Preclinical studies of intra-arterial chemotherapy using mitomycin C microspheres]F Endoh, S Fujimoto, Y Kitsukawa, et al.

Journal of Viral Hepatitis|February 22, 2005

Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapyK Imanaka, S Tamura, K Fukui, et al.

Microbiology and Immunology|January 1, 1987

Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides--studies on active components and structural requirementsA Kawasaki, H Takada, S Kotani, et al.

The Journal of Clinical Investigation|January 1, 1995

Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaquesJ Miyagawa, S Higashiyama, S Kawata, et al.

Pageof 67

Showing results (461-470 of 666) with videos related to

Sort By:

Pageof 67

Journal of Hepatology|January 1, 1990

Inhibitory effect of a new alpha-glucosidase inhibitor on fatty liver in Zucker fatty ratsY Inui, S Kawata, Y Matsuzawa, et al.

Journal of Hepatology|February 2, 1999

Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosisH Tsushima, S Kawata, S Tamura, et al.

Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1987

[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT]M Inada, Y Minami, S Kawata, et al.

Infection and Immunity|August 1, 1979

Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigsH Takada, M Tsujimoto, S Kotani, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995

Increased mitogenic response to heparin-binding epidermal growth factor-like growth factor in vascular smooth muscle cells of diabetic ratsK Fukuda, Y Inui, S Kawata, et al.

Journal of Lipid Research|August 1, 1995

Increased proportion of plasma apoB-48 to apoB-100 in non-insulin-dependent diabetic rats: contribution of enhanced apoB mRNA editing in the liverM Yamane, S Jiao, S Kihara, et al.

Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1984

[Preclinical studies of intra-arterial chemotherapy using mitomycin C microspheres]F Endoh, S Fujimoto, Y Kitsukawa, et al.

Journal of Viral Hepatitis|February 22, 2005

Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapyK Imanaka, S Tamura, K Fukui, et al.

Microbiology and Immunology|January 1, 1987

Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides--studies on active components and structural requirementsA Kawasaki, H Takada, S Kotani, et al.

The Journal of Clinical Investigation|January 1, 1995

Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaquesJ Miyagawa, S Higashiyama, S Kawata, et al.

Pageof 67